We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
EPHEDRINE-HAMELN (Hameln Pharma Pty Ltd)
Product name
EPHEDRINE-HAMELN
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
128 (255 working days)
Active ingredients
ephedrine hydrochloride
Registration type
New generic medicine
Indication
The treatment of hypotension secondary to spinal anaesthesia